2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis      90D16D20B18D6C2F67C5D476A40ED8A9 10.1002/art.40726  INTRODUCTION Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease associated with psoriasis, manifesting most commonly with peripheral arthritis, dactylitis, enthesitis, and spondylitis. Nail lesions, including pitting and onycholysis, occur in ~80-90% of patients with PsA. The incidence of PsA is ~6 per 100,000 per year, and the prevalence is ~1-2 per 1,000 in the general population PsA affects men and women equally. The distribution of the peripheral arthritis varies from asymmetric oligoarthritis (involving ≤4 joints) to symmetric polyarthritis (involving ≥5 joints). Distal interphalangeal joints are commonly affected and, in some patients, are the only affected joints. Axial disease, when present, usually occurs together with peripheral arthritis. Some patients present with rapidly